Cost-effectiveness analyses of umeclidinium bromide 62.5 mcg versus glycopyrronium 44 mcg and umeclidinium bromide 62.5 mcg versus tiotropium 18 mcg in patients with chronic obstructive pulmonary disease in the UK Meeting Abstract


Authors: Shah, D.; Driessen, M.; Risebrough, N.; Baker, T. M.; Naya, I.; Lloyd, E. J.; Briggs, A.; Ismaila, A.
Abstract Title: Cost-effectiveness analyses of umeclidinium bromide 62.5 mcg versus glycopyrronium 44 mcg and umeclidinium bromide 62.5 mcg versus tiotropium 18 mcg in patients with chronic obstructive pulmonary disease in the UK
Meeting Title: 22nd Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
Journal Title: Value in Health
Volume: 20
Issue: 5
Meeting Dates: 2017 May 20-24
Meeting Location: Boston, MA
ISSN: 1098-3015
Publisher: Elsevier Science, Inc.  
Date Published: 2017-05-01
Start Page: A202
Language: English
ACCESSION: WOS:000405448002361
PROVIDER: wos
DOI: 10.1016/j.jval.2017.05.005
Notes: Meeting Abstract: PRS15 -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Andrew   Briggs
    11 Briggs